Triple negative breast cancer
A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
10
There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population.
8
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
11
Androgen receptor expression in triple-negative breast cancer
80
Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer
5
Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
17
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.
7
Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients.
12
The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.
13
A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.
7
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.
20
Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.
7
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
14
Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
11
Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer
7
J. Bras. Patol. Med. Lab. vol.51 número6
10
Perfil molecular do câncer de mama triplo negativo: Uma revisão sistemática / Molecular profile of negative triple breast cancer: A systematic review
21
Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
11
An update on breast cancer multigene prognostic tests-emergent clinical biomarkers
12
Rev. Bras. Ginecol. Obstet. vol.37 número7
6